Article Details
Retrieved on: 2024-12-18 20:31:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the positive phase 3 trial results of MannKind Corporation’s inhalable insulin (Afrezza) for pediatric diabetes patients. It highlights the efficacy and safety relative to traditional injections, aligning with concepts of diabetes medication and insulin delivery.
Article found on: www.drugtopics.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here